Grenada vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Grenada
100.0%
in 2019
South-East Asia (WHO region)
94.0%
in 2024
Grenada rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Grenada
- South-East Asia (WHO region)
How they compare
Grenada currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Grenada's figure about 1.1 times South-East Asia (WHO region)'s.
Across all 5 years both countries report, Grenada has been ahead every year.
Grenada ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Grenada has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Grenada | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 45.5% | 54.5% | Grenada |
| 2010s | 100.0% | 82.7% | 17.3% | Grenada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Grenada or South-East Asia (WHO region)?
- Grenada, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2019.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Grenada and South-East Asia (WHO region)?
- 6.0%, with Grenada ahead.
- How many years of comparable data are there for Grenada and South-East Asia (WHO region)?
- 5 years are reported by both, from 2008 to 2019.
- How do Grenada and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Grenada ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.